2021
DOI: 10.6023/cjoc202007073
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Anti-proliferative Activity of Indole-2-amide Derivatives as Cyclooxygenase-2/5-lipoxygenase (COX-2/5-LOX) Dual Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…The phenoxy acetamide, indole, chalcone thiosemicarbazone, and quinoline are important groups in anti-inflammatory agents [47,107,108]. Huang, Qian, and coworkers designed indole-2-amides as anti-inflammatory drugs [33,109]. Results showed that 40, 41, 42 and 43 (Figure 4) present interesting anti-inflammatory properties, with 40 being the most promising compound with COX-2 selectivity and dual COX-2/5-LOX activity binding in the same way as coxibs into the COX-2 active site [33].…”
Section: Multitarget Drugsmentioning
confidence: 99%
“…The phenoxy acetamide, indole, chalcone thiosemicarbazone, and quinoline are important groups in anti-inflammatory agents [47,107,108]. Huang, Qian, and coworkers designed indole-2-amides as anti-inflammatory drugs [33,109]. Results showed that 40, 41, 42 and 43 (Figure 4) present interesting anti-inflammatory properties, with 40 being the most promising compound with COX-2 selectivity and dual COX-2/5-LOX activity binding in the same way as coxibs into the COX-2 active site [33].…”
Section: Multitarget Drugsmentioning
confidence: 99%
“…Currently, only selected COXIBs such as celecoxib, etoricoxib, or the prodrug parecoxib are on the market due to an increased risk for cardiovascular incidents such as stroke and heart attacks described after long-term treatment with, e.g., rofecoxib or valdecoxib. In this context, ongoing efforts are made to identify COXIBs with optimized pharmacological properties, among them are molecular hybrids, such as dual inhibitors targeting simultaneously the COX and LOX pathway [ 14 , 15 ] or, additionally, releasing gasotransmitters such as H 2 S [ 16 ] or, as targeted herein, nitric oxide (NO • ) [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%